retatrutide safety clinical trial Contraindications: Risks and Considerations for Patients Retatrutide Availability & Timeline |

As an example, Zepbound (tirzepatide), is approved by the FDA for chronic weight management in adults with obesity (BMI of 30 kg/m2 or greater) or overweight (BMI of 27 kg/m2 or greater) with at least one weight-related condition, which can include conditions other than type 2 diabetes

El-Haggar SM, Hafez YM, El Sharkawy AM, Khalifa M

The first Phase 3 results (TRIUMPH-4) were just released in December 2025

In addition, GLP-1R agonist have shown promise in the MASLD (Romero-Gmez et al., 2023)

Imagine losing 2030% of your body weightwithout extreme diets or hours in the gym

If you didnt use an HSA or FSA, you might be able to deduct the cost on your tax return if you itemize deductions, but only if your total medical expenses are high enough to exceed the 7.5% AGI threshold